Next Up

Preclinical Immuno-Oncology: Online

18 May 2022 |

BST (UTC+1)

18 May 2022

BST (UTC+1)

29 Sep 2022
Thu, 29 September 2022

Immuno UK: In-Person

Designing & delivering innovative immunotherapies to transform cancer care.

03 Oct 2022
Mon, 03 October 2022

Immuno US: In-Person

Discuss the latest strategies to harness the immune system for the development of innovative therapeutics

22 Nov 2022
Tue, 22 November 2022

Tumour Microenvironment: Online

Mar 2023
March 2023

Immuno UK: In-Person

More Information Coming Soon

Highlights

Image of Ian Wilson with PET scan background
Discussion Group Report
Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.
By Tom Cohen |
14 April 2022
Translational & Preclinical Development
Commentary
By Tom Cohen |
08 Apr 2022
Translational & Preclinical Development
Insight Article
By Tom Cohen |
07 Apr 2022
Biomarkers in Immuno-Oncology

In-Depth

Discussion Group Report
Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.
14 April 2022
Commentary
Oxford Global’s Immuno Week showcased new ways of reprogramming the immune system to treat malignancy with TCR-T.
08 April 2022
Insight Article
Early and effective treatment of cancers could mean the difference between life and death. Therefore, companion diagnostics and biomarker discovery could be considered one of the most important avenues to explore in immuno-oncology.
07 April 2022
Insight Article
Experts discuss elusively successful therapies and the rising costs that come with new technologies.
30 March 2022

[sponsor section - bespoke content]

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Immuno